NCT06780176 A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
| NCT ID | NCT06780176 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2025-01-13 |
| Primary Completion | 2030-01-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2025-01-13 with a primary completion date of 2030-01-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.
Eligibility Criteria
Inclusion Criteria: * Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami (UM), Sylvester Comprehensive Cancer Center (SCCC), Jackson Health Systems (JHS) for biopsy. * Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study. * Men and women 18 years of age and older are eligible to participate in the study. Exclusion Criteria: * Patients who are less than 18 years of age will be considered ineligible. * Patients unable to complete the survey.
Contact & Investigator
Neha Goel, MD, MPH
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT06780176 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06780176 currently recruiting?
Yes, NCT06780176 is actively recruiting participants. Contact the research team at goeln1@mskcc.org for enrollment information.
Where is the NCT06780176 trial being conducted?
This trial is being conducted at Los Angeles, United States, Miami, United States, New York, United States.
Who is sponsoring the NCT06780176 clinical trial?
NCT06780176 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Neha Goel, MD, MPH at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.